Insmed Inc (NASDAQ: INSM) is -7.84% lower on its value in year-to-date trading and has touched a low of $16.46 and a high of $32.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INSM stock was last observed hovering at around $28.39 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $28.56, the stock is 5.76% and 3.14% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing 0.60% at the moment leaves the stock 11.93% off its SMA200. INSM registered 69.29% gain for a year compared to 6-month gain of 15.11%. The firm has a 50-day simple moving average (SMA 50) of $15.29 and a 200-day simple moving average (SMA200) of -$7.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.58% loss in the last 1 month and extending the period to 3 months gives it a 0.78%, and is 4.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.06% over the week and 3.18% over the month.
Insmed Inc (INSM) has around 912 employees, a market worth around $4.24B and $305.21M in sales. Profit margin for the company is -245.59%. Distance from 52-week low is 73.51% and -10.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-73.74%).
Insmed Inc quarterly earnings per share for the current quarter are estimated at -$1.23 with sales reaching $78.58M over the same period.The EPS is expected to grow by 12.58% this year, but quarterly earnings will post 16.60% year-over-year. Quarterly sales are estimated to grow 21.80% in year-over-year returns.
377 institutions hold shares in Insmed Inc (INSM), with institutional investors hold 104.32% of the company’s shares. The shares outstanding are 147.98M, and float is at 144.65M with Short Float at 6.25%. Institutions hold 103.19% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 13.32 million shares valued at $281.06 million. The investor’s holdings represent 9.26% of the INSM Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 10.26 million shares valued at $216.45 million to account for 7.13% of the shares outstanding. The other top investors are Price (T.Rowe) Associates Inc which holds 10.17 million shares representing 7.07% and valued at over $214.64 million, while T. Rowe Price Investment Management, Inc. holds 5.77% of the shares totaling 8.3 million with a market value of $175.22 million.
Insmed Inc (INSM) Insider Activity
The most recent transaction is an insider sale by Adsett Roger, the company’s Chief Operating Officer. SEC filings show that Adsett Roger sold 5,251 shares of the company’s common stock on Jan 12 ’24 at a price of $28.63 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.
Insmed Inc disclosed in a document filed with the SEC on Jan 12 ’24 that Flammer Martina M.D. (Chief Medical Officer) sold a total of 4,667 shares of the company’s common stock. The trade occurred on Jan 12 ’24 and was made at $28.63 per share for $0.13 million. Following the transaction, the insider now directly holds 0.11 million shares of the INSM stock.
Still, SEC filings show that on Jan 10 ’24, Adsett Roger (Chief Operating Officer) disposed off 3,536 shares at an average price of $28.90 for $0.1 million. The insider now directly holds 153,810 shares of Insmed Inc (INSM).
